Huazhi Liquor Store: It is planned to distribute a cash dividend of 8.09 yuan for every 10 shares. Huazhi Liquor Store announced that the company's profit distribution plan for the first three quarters of 2024 has been approved by the shareholders' meeting. The company will distribute a cash dividend of RMB 8.09 to all shareholders for every 10 shares based on the existing total share capital of 417 million shares and the share capital of 408 million shares after 9,098,100 shares have been repurchased in the repurchase special securities account. The total amount of cash dividends actually distributed was 330 million. The distribution of rights and interests in date of record is December 19th, 2024, and the ex-dividend date is December 20th, 2024. This dividend does not involve bonus shares and capitalization of capital reserve.Yibin Paper: Terminate the issue of A shares to specific targets in 2022 and withdraw the application documents. Yibin Paper announced that the company held the 31st meeting of the 11th Board of Directors and the 22nd meeting of the 11th Board of Supervisors on December 12, 2024, and deliberated and passed the Proposal on Terminating the Issue of A shares to specific targets in 2022 and withdrawing the application documents. Considering the changes in market environment and policies, and considering the actual situation, the company decided to terminate the issuance of A shares to specific targets.Commander-in-Chief of Russian Navy: NATO increases its military activities in the Arctic.
Market News: South Korean President Yin Xiyue may release a recorded public speech.Li Ziyuan: The plan to reduce the holdings of directors, supervisors and senior managers has not been completed. Li Ziyuan announced the change. On October 1, 2024, the company disclosed the Announcement on the Plan to Reduce the Holdings of Some Directors, Supervisors and Senior Managers of Zhejiang Li Ziyuan Food Co., Ltd. Zhu Wenxiu and other six directors, supervisors and senior managers plan to reduce their holdings by centralized bidding, which does not exceed 1,190,607 shares, and does not exceed 1% of the company's total share capital. As of December 12, 2024, the above-mentioned directors, supervisors and senior managers reduced their holdings of 813,400 shares through centralized bidding. At present, the share reduction plan has not been completed.Japan's semiconductor sector rose collectively, with ADVANTEST up nearly 5%, DISCO up over 2% and Renesas Electronics up over 1%.
Spot gold just broke through the $2,710.00/oz mark, and the latest price was $2,709.91/oz, down 0.29% in the day; COMEX gold futures main force recently reported $2,744.30 per ounce, down 0.45% in the day.Truck manufacturer Paccar recalled more than 220,000 American cars due to electronic system problems. The National Highway Traffic Safety Administration (NHTSA) said on Thursday that truck manufacturer Paccar recalled 220,972 cars in the United States because there was a problem with the electronic control unit (ECU), which might affect the systems related to braking and stability control. NHTSA said that the recalled vehicles included some Peterbilt and Kenworth cars produced in 2021-2025.The tenth batch of national procurement officially opened, and the number of enterprises and varieties involved reached a record high. The tenth batch of centralized drug procurement organized by the state officially accepted the application materials of enterprises at 8: 00 this morning at No.398 Zhanyuan Road, Nanqiao New Town, Fengxian District, Shanghai. This centralized procurement involved 62 varieties and 263 product specifications, and the number of enterprises and varieties involved reached a record high. Among them, 33 enterprises competed for nine short-listed oral sustained-release formulations of sitagliptin. There are also a number of varieties that are billions in the market of public hospitals, such as doxorubicin hydrochloride liposome injection, cefoperazone injection, piperacillin injection, compound α -ketoacid oral sustained-release dosage form, norepinephrine injection and aspirin oral sustained-release dosage form. The sales scale in sample hospitals last year all exceeded 2 billion yuan. Hengrui Pharma, Kelun Pharmaceutical, Unacon and Zhengda Tianqing participated with many varieties. Note: According to the tenth batch of national adoption documents released before, the tenth batch of national adoption rules have changed a lot, such as canceling the protection mechanism of 50% price reduction and increasing the fuse recovery mechanism by 1.8 times, and the number of B-certified enterprises affects the number of final finalists.
Strategy guide 12-13
Strategy guide 12-13
Strategy guide 12-13